Asciminib as initial therapy for patients with chronic myeloid leukemia in chronic phase (CML-CP)-H. Jean Khoury Cure CML Consortium study Meeting Abstract
| Authors: | Atallah, E. L.; Visotcky, A.; Flynn, K. E.; Zhang, M. J.; Radich, J. P.; Yang, J.; Oehler, V. G.; Tantravahi, S. K.; Smith, B. D. D.; Ibarz, J. P.; Sweet, K.; Mauro, M.; Druker, B. J.; Thompson, J. E.; Maldonado-Schmidt, S.; Baim, A.; Schiffer, C. A.; Kota, V. K.; Cortes, J. E. |
| Abstract Title: | Asciminib as initial therapy for patients with chronic myeloid leukemia in chronic phase (CML-CP)-H. Jean Khoury Cure CML Consortium study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 3885 |
| End Page: | 3886 |
| Language: | English |
| ACCESSION: | WOS:000893223203409 |
| DOI: | 10.1182/blood-2022-160172 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
